Daniel Joyce

Daniel Joyce

Auto-generated profile, based on publicly available information

Daniel Joyce

Department of General Surgery, Digestive Diseases and Surgery Institute, Cleveland Clinic Foundation, Cleveland, USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 May 2023 in Surgical Endoscopy
Verified
Journal Article
Closed access
PDF file
RGRajat Garg
Rajat Garg
KTKomal Thind
Komal Thind
JBJaideep Bhalla
Jaideep Bhalla
MSMarian T. Simonson
Marian T. Simonson
CSC. Roberto Simons-Linares
C. Roberto Simons-Linares
PCPrabhleen Chahal
Prabhleen Chahal

22 August 2025 in Digestive Diseases and Sciences
Verified
Journal Article
Open access
PDF file
ACArjun Chatterjee
Arjun Chatterjee
RPRenan Prado
Renan Prado
CFClifton G Fulmer
Clifton G Fulmer
CCChristopher Coppa
Christopher Coppa
DJDaniel Joyce
Daniel Joyce
TSTyler Stevens
Tyler Stevens
Background: The widespread use of modern, high-resolution cross-sectional imaging has led to increased detection of pancreatic cystic lesions (PCLs), which have varying malignant potential. While most require periodic radiographic surveillance, some warrant biopsy or surgical excision. Methods: We conducted a narrative review of the literature focusing on the diagnostic accuracy of imaging and the role of endoscopic and molecular tools in PCL evaluation. Results: Cross-sectional imaging correctly classifies cyst type based on morphological features in approximately 50% of cases, with MRI generally outperforming CT. Endoscopic ultrasonography (EUS) is particularly useful when clinical and imaging findings are inconclusive or when high-risk features are present. In selected cases, such features may prompt direct surgical intervention. EUS-guided fine-needle aspiration of cyst fluid for chemical, genetic, and cytological analysis helps differentiate neoplastic mucinous cysts—such as intraductal papillary mucinous neoplasms and mucinous cystic neoplasms—from benign, non-mucinous cysts. Conclusions: Accurate diagnosis of PCLs requires a multimodal approach combining high-quality imaging, EUS evaluation, and cyst fluid analysis. Advances in biomarker development hold promise for improving risk stratification and guiding individualized management strategies.